Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bile acid pool represents the total circulating mass of bile acids within the enterohepatic circulation. It plays a crucial role in lipid digestion, cholesterol homeostasis, and cell signaling. The pool is composed primarily of cholic acid (CA), chenodeoxycholic acid (CDCA), and deoxycholic acid (DCA), and its size and composition are dynamic, cycling multiple times per day. Alterations in the bile acid pool can have significant clinical consequences, making it a relevant factor in various liver and metabolic disorders.
Varies depending on the specific drug and its interaction with bile acid metabolism or signaling. For example, bile acid sequestrants bind bile acids in the intestine, preventing their reabsorption and promoting their excretion. Ursodeoxycholic acid (UDCA) alters the composition of the bile acid pool.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bile Acid Pool (BAP).